0001127602-12-026238.txt : 20120912
0001127602-12-026238.hdr.sgml : 20120912
20120912172412
ACCESSION NUMBER: 0001127602-12-026238
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120911
FILED AS OF DATE: 20120912
DATE AS OF CHANGE: 20120912
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMGEN INC
CENTRAL INDEX KEY: 0000318154
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 953540776
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320
BUSINESS PHONE: (805)447-1000
MAIL ADDRESS:
STREET 1: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320
FORMER COMPANY:
FORMER CONFORMED NAME: AMGEN
DATE OF NAME CHANGE: 19870305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SHARER KEVIN W
CENTRAL INDEX KEY: 0001185618
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-12477
FILM NUMBER: 121088608
MAIL ADDRESS:
STREET 1: AMGEN INC.
STREET 2: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320-1799
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2012-09-11
0000318154
AMGEN INC
AMGN
0001185618
SHARER KEVIN W
ONE AMGEN CENTER DRIVE
THOUSAND OAKS
CA
91320-1799
1
Common Stock
2012-09-11
4
M
0
1598
62.55
A
102616
D
Common Stock
2012-09-11
4
M
0
193402
62.55
A
296018
D
Common Stock
2012-09-11
4
M
0
79625
58.43
A
375643
D
Common Stock
2012-09-11
5
G
0
E
274625
0
A
423119
I
Living Trust
Common Stock
2012-09-11
5
G
0
E
274625
0
D
101018
D
Common Stock
2012-09-11
4
S
0
274625
83.9618
D
148494
I
Living Trust
Common Stock
2012-09-11
4
S
0
50585
83.9639
D
97909
I
Living Trust
Common Stock
2012-09-11
4
S
0
24415
83.9665
D
73494
I
Living Trust
Common Stock
4433.6295
I
By 401(k) Plan
Iso (Right to Buy)
62.55
2012-09-11
4
M
0
1598
0
D
2011-04-26
2014-04-26
Common Stock
1598
0
D
Nqso (Right to Buy)
62.55
2012-09-11
4
M
0
193402
0
D
2008-04-26
2014-04-26
Common Stock
193402
0
D
Nqso (Right to Buy)
58.43
2012-09-11
4
M
0
79625
0
D
2011-04-26
2020-04-26
Common Stock
79625
159250
D
These shares are being transferred to the reporting person's Living Trust.
These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 9,250 RSUs which fully vest on 4/28/2013; 22,750 RSUs which vest in two equal annual installments of 11,375 each commencing 4/26/2013; 60,000 RSUs which vest in two equal installments of 19,800 each on 4/25/2013 and 4/25/2014 and one installment of 20,400 on 4/25/2015; and 8,933 RSUs which vest in three installments of 2,947, 2,948 and 3,038 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis.
These shares include 85 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
The price reported is an average price. The prices ranged from $83.79 to $84.12 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.
The price reported is an average price. The prices ranged from $83.795 to $84.16 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.
These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.
/s/ Andrea Robinson, Attorney-in-Fact for Mr. Sharer
2012-09-12